Literature DB >> 21700100

Pseudophakic negative dysphotopsia: Surgical management and new theory of etiology.

Samuel Masket1, Nicole R Fram.   

Abstract

PURPOSE: To evaluate the benefit of various surgical methods to address pseudophakic negative dysphotopsia.
SETTING: Private practice, Los Angeles, California, USA.
DESIGN: Interventional case series.
METHODS: The following 4 surgical methods were used to treat negative dysphotopsia: secondary piggyback intraocular lens (IOL) implantation, reverse optic capture, in-the-bag IOL exchange, and iris suture fixation. Ultrasound biomicroscopy (UBM) was used to analyze posterior chamber anatomy. The primary outcome was partial or complete resolution of the negative dysphotopsia symptoms 3 months postoperatively.
RESULTS: Twelve eyes of 11 patients with negative dysphotopsia had surgical treatment. All 10 patients who had piggyback IOL implantation or reverse optic capture had partial or complete resolution of symptoms by 3 months. No patient who had in-the-bag IOL exchange (n = 3) or iris suture fixation of the capsular bag-IOL complex (n = 1) improved despite alteration of IOL material or edge design in the case of IOL exchange or UBM confirmation of posterior chamber collapse in the case of iris suture fixation of the capsular bag-IOL complex.
CONCLUSIONS: Consistent with a new hypothesis, resolution of negative dysphotopsia symptoms depended on IOL coverage of the anterior capsule edge rather than on collapse of the posterior chamber alone. Furthermore, negative dysphotopsia was not attributed to a particular IOL material or edge design. .
Copyright © 2011 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21700100     DOI: 10.1016/j.jcrs.2011.02.022

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  10 in total

1.  [Implantation of intraocular lenses in the ciliary sulcus].

Authors:  S Schulze; T Bertelmann; W Sekundo
Journal:  Ophthalmologe       Date:  2014-04       Impact factor: 1.059

2.  Determinants of patient satisfaction and function related to vision following cataract surgery in eyes with no visually consequential ocular co-morbidity.

Authors:  Clare Kirwan; John M Nolan; Jim Stack; Tara C B Moore; Stephen Beatty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-13       Impact factor: 3.117

3.  Treatment of negative dysphotopsia with supplementary implantation of a sulcus-fixated intraocular lens.

Authors:  Natalia Y Makhotkina; Tos T J M Berendschot; Henny J M Beckers; Rudy M M A Nuijts
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-07       Impact factor: 3.117

4.  Is the Memory Effect of the Blind Spot Involved in Negative Dysphotopsia after Cataract Surgery?

Authors:  Martin Wenzel; Rupert Menapace; Timo Eppig; Achim Langenbucher
Journal:  J Ophthalmol       Date:  2015-09-06       Impact factor: 1.909

5.  Swivel haptics anterior capsule-fixated intraocular lens.

Authors:  Sri Ganesh; Sheetal Brar
Journal:  Indian J Ophthalmol       Date:  2018-09       Impact factor: 1.848

6.  Distinct differences in anterior chamber configuration and peripheral aberrations in negative dysphotopsia.

Authors:  Luc van Vught; Gregorius P M Luyten; Jan-Willem M Beenakker
Journal:  J Cataract Refract Surg       Date:  2020-07       Impact factor: 3.351

7.  Clinical experience with an anti-dysphotopic intraocular lens.

Authors:  Zsófia Rupnik; Ágnes Elekes; Péter Vámosi
Journal:  Saudi J Ophthalmol       Date:  2022-08-29

8.  Refractive index and its impact on pseudophakic dysphotopsia.

Authors:  Bryce R Radmall; Anne Floyd; Zack Oakey; Randall J Olson
Journal:  Clin Ophthalmol       Date:  2015-07-20

9.  Reverse optic capture to stabilize a toric intraocular lens.

Authors:  Howard V Gimbel; Anika Amritanand
Journal:  Case Rep Ophthalmol       Date:  2013-09-26

10.  Simulation of photic effects after cataract surgery for off-axis light sources.

Authors:  Pooria Omidi; Alan Cayless; Achim Langenbucher
Journal:  PLoS One       Date:  2022-01-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.